Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Understanding Natural Cycle IVF; What Is It and Who Is It Best For

Fertility specialist Dr. Ralf Zimmermann with Neway Fertility, with tips on this common assisted reproduction option and who it can help.


News provided by

MCPR, LLC

Dec 11, 2018, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Ralf Zimmermann
Dr. Ralf Zimmermann

NEW YORK, Dec. 11, 2018 /PRNewswire-PRWeb/ -- Considering IVF (in vitro fertilization) as an option to expand your family, but daunted by all the medications traditionally used during the popular fertility treatment? Then natural IVF may be the right option for you, says fertility specialist Ralf Zimmermann, MD, Medical Director of Neway Fertility.

The very first IVF baby, born in 1978, was actually conceived using natural cycle IVF. This type of IVF cycle allows for a naturally selected, mature egg to be retrieved and fertilized using little to no medication, says Dr. Zimmermann, also on the faculty of Columbia University's Division of Reproductive Endocrinology and Infertility.

A variation of the procedure, known as natural cycle IVF/M, retrieves not only a woman’s mature egg from her ovary, but immature eggs from smaller follicles.

Post this

A variation of the procedure, known as natural cycle IVF/M, retrieves not only a woman's mature egg from her ovary, but immature eggs from smaller follicles. Either way, patients return to their doctor's office for 5 to 6 days of monitoring to determine when ovulation will occur and schedule the retrieval date. Once obtained, the egg is fertilized in the laboratory, allowed to develop in a culture dish for 3 to 5 days, and then implanted back into the woman – just like traditional IVF.

"Natural cycle IVF is extremely similar to standard IVF, but without using large amounts of medications to stimulate the ovary to produce multiple eggs," Dr. Zimmermann explains. "For some women, this option is more pleasing to them and may also make better sense from a fertility standpoint."

Who chooses natural cycle IVF?
Natural cycle IVF can be an optimal choice for patients for several reasons, Dr. Zimmermann says. These include:

  •     You don't want or can't take all the medications needed for standard IVF: Certain medical diagnoses require patients to forego taking medications or hormones, he says. "Other times, a woman simply doesn't wish to deal with the regimented schedule of medications, frequent office visits, or the need to introduce many drugs into her body," Dr. Zimmermann adds.
  •     You need to complete a cycle in a short time frame: Because natural cycle IVF doesn't require a great deal of preparation time, it works within a tight turnaround, he says. "This can happen when swift treatment of another medical condition doesn't allow the luxury of time for IVF," he adds.
  •     Your previous standard IVF attempts haven't worked: Even if ovarian stimulation through traditional IVF has repeatedly failed to produce multiple embryos, natural cycle IVF can give you the opportunity to continue the IVF process. "This approach may not necessarily be best for everyone, but your doctor can let you know if it could help you," Dr. Zimmermann notes.
  •     Your infertility is due to low- or poor-quality sperm: When a woman is otherwise fertile but cannot conceive normally because of her male partner's infertility, natural cycle IVF may present the most low-tech way to avoid unnecessary ovarian stimulation or the possibility of multiple embryos, he says.

Top reasons to choose natural cycle IVF
Among the biggest benefits of choosing natural cycle IVF? In addition to being nearly drug-free, it's also less expensive than standard IVF, Dr. Zimmermann explains.

Other benefits include:

  •     No risk of ovarian hyperstimulation syndrome: When taking fertility drugs to increase their egg production for IVF, some women experience this unpleasant condition. Symptoms of ovarian hyperstimulation syndrome include vomiting, diarrhea, pain near the ovaries, dark urine, decreased urination, rapid weight gain and shortness of breath.
  •     Less monitoring: Standard IVF requires many regularly scheduled office visits for blood tests and ultrasounds. Natural cycle IVF still requires some monitoring, but far less.
  •     Ovarian hyperstimulation isn't needed: Some women, for religious or other reasons, don't want to produce excess eggs that may later be discarded. Since natural cycle IVF only uses naturally produced eggs, this isn't a factor, Dr. Zimmermann says.

"Natural cycle IVF can be less expensive, less time-consuming and less complicated than standard IVF," he says. "If you want to know if natural cycle IVF is a good choice for you, talk to a fertility specialist. Your medical history will be reviewed and you can discuss the pros and cons of natural cycle IVF for your individual circumstances."

Neway Fertility is one of New York's leading fertility centers specializing in customized and effective fertility treatments. http://www.newayfertility.com

Ralf Zimmermann, MD, is a board-certified reproductive endocrinologist and medical director of Neway Fertility in New York City.

SOURCE MCPR, LLC

Related Links

www.mcprpublicrelations.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.